| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
KRYS
Krystal Biotech
|
Jun 17, 2026 | BUY |
Strong Buy
-28.2% avg upside
19 analysts
|
$361.00
3.78% Upside
|
+1.9% |
|
EWTX
Edgewise Therapeutics
|
Jun 16, 2026 | BUY |
Strong Buy
+22.5% avg upside
14 analysts
|
$45.00
22.32% Upside
|
+8.4% |
|
NVCT
Nuvectis Pharma
|
Jun 15, 2026 | BUY |
Strong Buy
+30.3% avg upside
6 analysts
|
$13.00
5.87% Downside
|
· |
|
KURA
Kura Oncology
|
Jun 15, 2026 | BUY |
Strong Buy
+161.3% avg upside
26 analysts
|
$40.00
302.74% Upside
|
+0.3% |
|
CLDX
Celldex
|
Jun 15, 2026 | BUY |
Strong Buy
+20.6% avg upside
28 analysts
|
$42.00
29.46% Upside
|
+1.0% |
|
ANAB
AnaptysBio
|
Jun 10, 2026 | BUY |
Strong Buy
+26.1% avg upside
26 analysts
|
$95.00
65.27% Upside
|
+12.5% |
|
FR:ALSEN
Sensorion SAS
|
Jun 10, 2026 | HOLD |
Strong Buy
+547.2% avg upside
5 analysts
|
— | · |
|
STTK
Shattuck Labs
|
Jun 09, 2026 | BUY |
Strong Buy
+369.1% avg upside
14 analysts
|
$18.00
263.57% Upside
|
+1.4% |
|
ANL
Adlai Nortye Ltd. Sponsored ADR
|
Jun 09, 2026 | BUY |
Strong Buy
+113.9% avg upside
6 analysts
|
$20.00
98.07% Upside
|
· |
|
BCDA
BioCardia
|
Jun 09, 2026 | BUY |
Strong Buy
+1502.2% avg upside
5 analysts
|
$25.00
2484.26% Upside
|
· |
|
BMEA
Biomea Fusion
|
Jun 08, 2026 | BUY |
Strong Buy
+1037.0% avg upside
15 analysts
|
$4.00
238.91% Upside
|
· |
|
TVTX
Travere Therapeutics
|
Jun 05, 2026 | BUY |
Strong Buy
-16.0% avg upside
22 analysts
|
$67.00
21.50% Upside
|
+13.6% |
|
PHAR
Pharming Group
|
Jun 04, 2026 | BUY |
Strong Buy
+199.1% avg upside
4 analysts
|
$37.00
187.46% Upside
|
· |
|
GUTS
Fractyl Health, Inc.
|
Jun 04, 2026 | BUY |
Strong Buy
+449.9% avg upside
6 analysts
|
$8.00
831.99% Upside
|
-8.7% |
|
IOVA
Iovance Biotherapeutics
|
Jun 04, 2026 | BUY |
Strong Buy
+225.7% avg upside
24 analysts
|
$9.00
130.25% Upside
|
· |
|
ATNM
Actinium Pharmaceuticals
|
Jun 03, 2026 | BUY |
Strong Buy
+633.6% avg upside
11 analysts
|
$4.00
288.41% Upside
|
· |
|
TNYA
Tenaya Therapeutics
|
Jun 03, 2026 | BUY |
Strong Buy
+1268.7% avg upside
11 analysts
|
$3.00
310.55% Upside
|
· |
|
RIGL
Rigel
|
Jun 02, 2026 | BUY |
Strong Buy
-27.5% avg upside
17 analysts
|
$57.00
73.24% Upside
|
+20.9% |
|
APRE
Aprea Therapeutics
|
Jun 01, 2026 | BUY |
Buy
+3098.2% avg upside
7 analysts
|
$1.20
67.85% Upside
|
· |
|
CMPX
Compass Therapeutics
|
Jun 01, 2026 | BUY |
Strong Buy
+373.3% avg upside
19 analysts
|
$24.00
1088.15% Upside
|
-9.0% |
|
LCTX
Lineage Therap
|
May 26, 2026 | BUY |
Strong Buy
+342.8% avg upside
16 analysts
|
$9.00
643.88% Upside
|
-6.2% |
|
PROK
ProKidney
|
May 18, 2026 | BUY |
Buy
+260.7% avg upside
12 analysts
|
$12.00
555.70% Upside
|
· |
|
NEUP
Neuphoria Therapeutics
|
May 18, 2026 | HOLD |
Strong Buy
+365.8% avg upside
6 analysts
|
— | · |
|
LSTA
Lisata Therapeutics
|
May 18, 2026 | HOLD |
Buy
+267.9% avg upside
11 analysts
|
— | · |
|
KAPA
Kairos Pharma, Ltd.
|
May 14, 2026 | BUY |
Strong Buy
+2051.2% avg upside
4 analysts
|
$12.00
2690.77% Upside
|
· |
|
CLNN
Clene
|
May 14, 2026 | BUY |
Strong Buy
+442.4% avg upside
11 analysts
|
$31.00
415.86% Upside
|
-3.0% |
|
PDSB
PDS Biotechnology
|
May 14, 2026 | BUY |
Strong Buy
+1493.1% avg upside
11 analysts
|
$15.00
1470.58% Upside
|
· |
|
ARMP
Armata Pharmaceuticals
|
May 14, 2026 | BUY |
Strong Buy
+97.7% avg upside
4 analysts
|
$15.00
111.94% Upside
|
-13.1% |
|
CALC
CalciMedica
|
May 13, 2026 | HOLD |
Buy
+3672.8% avg upside
9 analysts
|
— | +24.6% |
|
CAPR
Capricor Therapeutics
|
May 13, 2026 | BUY |
Strong Buy
+68.2% avg upside
12 analysts
|
$60.00
111.40% Upside
|
-5.1% |
|
ATYR
aTyr Pharma
|
May 12, 2026 | HOLD |
Buy
+2023.9% avg upside
17 analysts
|
— | -1.9% |
|
CYTK
Cytokinetics
|
May 12, 2026 | BUY |
Strong Buy
+8.9% avg upside
36 analysts
|
$140.00
77.71% Upside
|
+5.6% |
|
LXRX
Lexicon Pharmaceuticals
|
May 08, 2026 | BUY |
Buy
+98.6% avg upside
9 analysts
|
$6.00
198.42% Upside
|
-4.5% |
|
OABI
OmniAb
|
May 08, 2026 | BUY |
Strong Buy
+232.4% avg upside
10 analysts
|
$11.00
370.11% Upside
|
+37.4% |
|
LGND
Ligand Pharma
|
May 07, 2026 | BUY |
Strong Buy
-20.8% avg upside
15 analysts
|
$289.00
5.14% Upside
|
+30.7% |
|
NAMS
NewAmsterdam Pharma Company
|
May 06, 2026 | BUY |
Strong Buy
+56.4% avg upside
18 analysts
|
$52.00
74.37% Upside
|
-3.7% |
|
QTTB
Q32 Bio
|
May 05, 2026 | BUY |
Buy
+345.2% avg upside
24 analysts
|
$13.00
9.27% Upside
|
+7.0% |
|
ESPR
Esperion
|
May 04, 2026 | HOLD |
Buy
+701.2% avg upside
22 analysts
|
$3.16
0.23% Upside
|
+1.0% |
|
VKTX
Viking Therapeutics
|
Apr 30, 2026 | BUY |
Strong Buy
+141.1% avg upside
30 analysts
|
$102.00
235.73% Upside
|
-4.9% |
|
CVKD
Cadrenal Therapeutics, Inc.
|
Apr 30, 2026 | BUY |
Strong Buy
+728.6% avg upside
2 analysts
|
$13.00
271.35% Upside
|
· |
|
XOMA
XOMA Royalty Corporation
|
Apr 30, 2026 | HOLD |
Buy
-46.5% avg upside
11 analysts
|
$39.00
6.90% Downside
|
+1.8% |
|
AU:BOT
Botanix Pharmaceuticals Limited
|
Apr 29, 2026 | BUY |
Strong Buy
+4445.5% avg upside
1 analyst
|
$1.00
4445.52% Upside
|
· |
|
TPST
Tempest Therapeutics
|
Mar 31, 2026 | BUY |
Buy
+1669.9% avg upside
18 analysts
|
$11.00
794.35% Upside
|
+8.5% |
|
PHGE
BiomX
|
Mar 09, 2026 | HOLD |
Buy
+4708.7% avg upside
4 analysts
|
— | -91.5% |
|
FBIO
Fortress Biotech
|
Feb 23, 2026 | BUY |
Strong Buy
+164.2% avg upside
12 analysts
|
$17.00
468.61% Upside
|
-30.1% |
|
VYNE
VYNE Therapeutics
|
Dec 17, 2025 | HOLD |
Strong Buy
+2024.6% avg upside
9 analysts
|
— | +9.3% |
|
SE:MVIR
Medivir AB
|
Oct 23, 2025 | BUY |
Strong Buy
+2451.0% avg upside
2 analysts
|
$54.00
3229.28% Upside
|
· |
|
BLRX
Bioline RX Ltd Sponsored ADR
|
Aug 14, 2025 | BUY |
Strong Buy
+222.8% avg upside
6 analysts
|
$26.00
722.80% Upside
|
-18.6% |
|
XBIO
Xenetic Biosciences
|
Aug 13, 2025 | HOLD |
Hold
2 analysts
|
— | +0.3% |
|
TSE:SVA
Sernova
|
Jul 09, 2025 | BUY |
Strong Buy
+2405.8% avg upside
3 analysts
|
$6.00
3900.07% Upside
|
· |
|
GNTA
Genenta Science SpA Sponsored ADR
|
Jul 02, 2025 | BUY |
Strong Buy
+832.6% avg upside
3 analysts
|
$25.00
1388.11% Upside
|
-81.8% |
|
PTN
Palatin Technologies
|
Jun 20, 2025 | HOLD |
Strong Buy
+899.7% avg upside
4 analysts
|
— | +86.0% |
|
DE:MDG1
Medigene
|
Apr 08, 2025 | HOLD |
Strong Buy
+37283.2% avg upside
2 analysts
|
— | · |
|
TSE:APS
Aptose Biosciences
|
Mar 31, 2025 | BUY |
Strong Buy
+4103.9% avg upside
10 analysts
|
$8.49
281.62% Upside
|
· |
|
BIORQ
Biora Therapeutics
|
Mar 31, 2025 | HOLD |
Strong Buy
+269249900.0% avg upside
6 analysts
|
— | · |
|
BPTSY
Biophytis
|
Feb 26, 2025 | HOLD |
Sell
+24.0% avg upside
2 analysts
|
— | -91.0% |
|
BRRGF
Oncoinvent ASA
|
Feb 26, 2025 | HOLD |
Hold
1 analyst
|
— | · |
|
PBLA
Panbela Therapeutics
|
Sep 25, 2024 | HOLD |
Buy
+4504404.6% avg upside
3 analysts
|
— | · |
|
TRAW
Traws Pharma
|
Sep 25, 2024 | HOLD |
Buy
+3604.5% avg upside
10 analysts
|
— | -73.3% |
|
MBIO
Mustang Bio
|
May 16, 2024 | BUY |
Strong Buy
+938.4% avg upside
5 analysts
|
$2.00
207.61% Upside
|
-95.9% |
|
GB:OXB
Oxford BioMedica
|
Nov 29, 2023 | HOLD |
Buy
+94.9% avg upside
3 analysts
|
— | · |
|
IMVIF
IMV
|
Aug 08, 2023 | HOLD |
Buy
+2417334899.9% avg upside
7 analysts
|
— | · |
|
XNCR
Xencor
|
Aug 07, 2023 | HOLD |
Strong Buy
+160.0% avg upside
27 analysts
|
— | -69.8% |
|
HURA
TuHURA Biosciences
|
Feb 09, 2023 | HOLD |
Strong Buy
+258.0% avg upside
8 analysts
|
— | -98.1% |
|
GNCAQ
Genocea Biosciences
|
Apr 29, 2022 | HOLD |
Strong Buy
+573999900.0% avg upside
10 analysts
|
— | · |
|
BYSI
Beyondspring
|
Apr 14, 2022 | HOLD |
Hold
+400.8% avg upside
8 analysts
|
— | -4.6% |
|
PVLA
Palvella Therapeutics
|
Nov 02, 2021 | BUY |
Strong Buy
+45.3% avg upside
27 analysts
|
$9.00
92.07% Downside
|
· |
|
SSKN
Strata Skin Sciences
|
Aug 23, 2021 | BUY |
Strong Buy
+4279.6% avg upside
5 analysts
|
$3.00
2089.81% Upside
|
-55.2% |
|
GB:0RIS
Targovax ASA
|
Aug 18, 2021 | BUY |
Strong Buy
+70.3% avg upside
1 analyst
|
$12.18
70.29% Upside
|
· |
|
NL:PHARM
Pharming Group
|
Aug 05, 2021 | BUY |
Strong Buy
+192.0% avg upside
4 analysts
|
$3.10
174.26% Upside
|
· |
|
AU:PTX
Prescient Therapeutics Limited
|
Nov 27, 2019 | HOLD |
Hold
1 analyst
|
— | · |
|
IRD
Opus Genetics
|
Aug 07, 2019 | HOLD |
Strong Buy
+154.5% avg upside
23 analysts
|
$3.00
26.32% Downside
|
· |
|
OTLC
Oncotelic Therapeutics
|
Apr 22, 2019 | HOLD |
Strong Buy
+7468.0% avg upside
5 analysts
|
— | · |
|
SCPX
Scorpius Holdings
|
Nov 16, 2018 | BUY |
Strong Buy
+1664672.7% avg upside
11 analysts
|
$6.00
545354.61% Upside
|
· |
|
SLS
SELLAS Life Sciences Group
|
Jul 31, 2018 | BUY |
Strong Buy
+768.2% avg upside
15 analysts
|
$4.00
50.33% Downside
|
-93.8% |
|
SNGX
Soligenix
|
Mar 16, 2018 | HOLD |
Buy
+726.0% avg upside
6 analysts
|
$2.70
575.87% Upside
|
-13.2% |
|
RBSH
Rebus Holdings
|
Jun 02, 2017 | BUY |
Strong Buy
+1999899.9% avg upside
2 analysts
|
— | · |
|
IMNN
Imunon
|
Apr 10, 2017 | BUY |
Buy
+705.8% avg upside
11 analysts
|
$21.00
1053.77% Upside
|
-42.4% |
|
VSTM
Verastem
|
Dec 07, 2016 | HOLD |
Strong Buy
+260.2% avg upside
23 analysts
|
$2.00
51.50% Downside
|
+276.3% |
|
TGTX
TG Therapeutics
|
Dec 07, 2016 | BUY |
Strong Buy
-34.4% avg upside
19 analysts
|
$33.00
37.99% Downside
|
· |
|
SRNE
Sorrento Therapeutics
|
Dec 05, 2016 | BUY |
Strong Buy
+2272627.3% avg upside
7 analysts
|
$15.00
1363536.27% Upside
|
-38.7% |
|
ENLV
Enlivex
|
Nov 29, 2016 | BUY |
Strong Buy
+3492.3% avg upside
4 analysts
|
$15.00
2312.78% Upside
|
-82.0% |
|
NTBLQ
Notable Labs
|
Nov 29, 2016 | BUY |
Buy
+809999900.0% avg upside
12 analysts
|
$17.00
1699999899.96% Upside
|
· |
|
IMMP
Immutep
|
Nov 28, 2016 | BUY |
Strong Buy
+1343.0% avg upside
7 analysts
|
$6.00
1503.36% Upside
|
-1.2% |
|
PALI
Palisade Bio
|
Nov 28, 2016 | BUY |
Strong Buy
+1347.1% avg upside
15 analysts
|
$15.60
734.19% Upside
|
-86.3% |
|
IMUC
ImmunoCellular Therapeutics
|
Nov 23, 2016 | BUY |
Strong Buy
+2515.4% avg upside
3 analysts
|
$8.00
3704.31% Upside
|
· |
|
CFRXQ
ContraFect
|
Nov 09, 2016 | HOLD |
Buy
+10969999900.0% avg upside
10 analysts
|
$2.20
219999900.07% Upside
|
· |
|
REGN
Regeneron
|
Oct 31, 2016 | BUY |
Strong Buy
+26.9% avg upside
57 analysts
|
$520.00
14.68% Downside
|
-1.7% |
|
DARE
Daré Bioscience
|
Oct 18, 2016 | BUY |
Strong Buy
+516.8% avg upside
14 analysts
|
$2.50
15.23% Upside
|
-85.6% |
|
DCOY
Decoy Therapeutics
|
Sep 13, 2016 | BUY |
Strong Buy
+338.9% avg upside
7 analysts
|
$26.00
328.35% Upside
|
· |
|
PSTV
Plus Therapeutics
|
Jun 27, 2016 | BUY |
Strong Buy
+688.7% avg upside
11 analysts
|
$11.00
161.84% Upside
|
-91.6% |
|
CRIS
Curis
|
Feb 29, 2016 | BUY |
Strong Buy
+1932.2% avg upside
12 analysts
|
$5.00
1087.64% Upside
|
-63.5% |
|
TLOG
Tetralogic Pharma
|
Jan 07, 2016 | BUY |
Strong Buy
+10833233.3% avg upside
3 analysts
|
$1.00
2499899.94% Upside
|
· |
|
MDGL
Madrigal Pharmaceuticals
|
Oct 21, 2015 | HOLD |
Strong Buy
-5.8% avg upside
31 analysts
|
$35.00
93.16% Downside
|
+73.8% |
|
CANF
Can-Fite BioPharma
|
May 31, 2015 | HOLD |
Strong Buy
+57.2% avg upside
8 analysts
|
$3.30
10.68% Upside
|
-23.0% |
|
LITS
Lite Strategy
|
Mar 23, 2015 | HOLD |
Buy
+1215.4% avg upside
13 analysts
|
$2.50
202.10% Upside
|
· |
|
LADX
LadRx
|
Sep 30, 2013 | BUY |
Strong Buy
+6535.5% avg upside
5 analysts
|
$9.00
8311.13% Upside
|
· |
|
AGEN
Agenus
|
Nov 09, 2012 | BUY |
Strong Buy
+164.7% avg upside
17 analysts
|
— | -27.8% |
|
AMRN
Amarin
|
Sep 11, 2012 | BUY |
Buy
-47.3% avg upside
18 analysts
|
$26.00
62.25% Upside
|
· |
|
MBOT
Microbot Medical
|
Jul 24, 2012 | BUY |
Strong Buy
+260.2% avg upside
7 analysts
|
$5.00
168.89% Upside
|
-16.8% |
|
BGMS
Bio Green Med Solution
|
Feb 04, 2010 | BUY |
Strong Buy
+1647.8% avg upside
7 analysts
|
$7.00
823.43% Upside
|
-75.2% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.